BAM
NVO

Blueshift Asset Management’s Novo Nordisk NVO Stock Holding History

Blueshift Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,873
Closed -$269K – 557
2025
Q1 		$269K Sell
3,873
-766
-17% -$63.3K 0.11% 291
2024
Q4 		$399K Buy
4,639
+2,700
+139% +$292K 0.15% 199
2024
Q3 		$231K Buy
+1,939
New +$259K 0.06% 322
2023
Q3 		– Sell
-2,924
Closed -$237K – 385
2023
Q2 		$237K Buy
+2,924
New +$239K 0.09% 270
2022
Q4 		– Sell
-10,834
Closed -$540K – 540
2022
Q3 		$540K Buy
+10,834
New +$580K 0.12% 263
2020
Q4 		– Sell
-6,234
Closed -$216K – 820
2020
Q3 		$216K Buy
+6,234
New +$208K 0.03% 530

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Blueshift Asset Management's NVO Position: Q2 2025 in Review

Blueshift Asset Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 3,873 shares — an estimated $269K sold.

Blueshift Asset Management first reported a position in NVO in Q3 2020 and held it in 6 quarters. The position peaked at $540K in Q3 2022. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Blueshift Asset Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 3,873 Novo Nordisk shares in Q2 2025, an estimated $269K.
  • Blueshift Asset Management first reported a position in Novo Nordisk in Q3 2020 and held it in 6 quarters.
  • Blueshift Asset Management's Novo Nordisk position peaked at $540K in Q3 2022.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Blueshift Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.